{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:08:24Z","timestamp":1790676504651,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Application of clinical features of capital city of science and Technology Commission","award":["Z171100001017082"],"award-info":[{"award-number":["Z171100001017082"]}]},{"name":"The Fund for Beijing Science & Technology Development of TCM","award":["JJ2016-14"],"award-info":[{"award-number":["JJ2016-14"]}]},{"name":"The Fund of Special research of TCM in Capital City","award":["17ZY02"],"award-info":[{"award-number":["17ZY02"]}]},{"name":"he National Key Sci-Tech Special\nProject of China","award":["2018ZX10302207"],"award-info":[{"award-number":["2018ZX10302207"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00262-019-02426-5","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T22:03:43Z","timestamp":1573596223000},"page":"2041-2054","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["PD-1+ TIGIT+ CD8+ T cells are associated with pathogenesis and progression of patients with hepatitis B virus-related hepatocellular carcinoma"],"prefix":"10.1007","volume":"68","author":[{"given":"Xiaoli","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxian","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"issue":"2","key":"2426_CR1","first-page":"87","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA 65(2):87\u2013108","journal-title":"CA"},{"issue":"12","key":"2426_CR2","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1002\/ijc.21731","volume":"118","author":"DM Parkin","year":"2006","unstructured":"Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118(12):3030\u20133044","journal-title":"Int J Cancer"},{"issue":"4","key":"2426_CR3","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/hep.27969","volume":"62","author":"C de Martel","year":"2015","unstructured":"de Martel C, Maucort-Boulch D, Plummer M, Franceschi S (2015) World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology 62(4):1190\u20131200","journal-title":"Hepatology"},{"issue":"4","key":"2426_CR4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jhep.2015.01.002","volume":"62","author":"GV Papatheodoridis","year":"2015","unstructured":"Papatheodoridis GV, Chan HL, Hansen BE, Janssen HL, Lampertico P (2015) Risk of hepatocellular carcinoma in chronic hepatitis B: assessment and modification with current antiviral therapy. J Hepatol 62(4):956\u2013967","journal-title":"J Hepatol"},{"issue":"6","key":"2426_CR5","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","volume":"60","author":"FS Wang","year":"2014","unstructured":"Wang FS, Fan JG, Zhang Z, Gao B, Wang HY (2014) The global burden of liver disease: the major impact of China. Hepatology 60(6):2099\u20132108","journal-title":"Hepatology"},{"issue":"8","key":"2426_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc.2017.51","volume":"17","author":"M De Palma","year":"2017","unstructured":"De Palma M, Biziato D, Petrova TV (2017) Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer 17(8):457\u2013474","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2426_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nri3789","volume":"15","author":"T Kitamura","year":"2015","unstructured":"Kitamura T, Qian BZ, Pollard JW (2015) Immune cell promotion of metastasis. Nat Rev Immunol 15(2):73\u201386","journal-title":"Nat Rev Immunol"},{"key":"2426_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2015.10.009","volume":"39","author":"DH Munn","year":"2016","unstructured":"Munn DH, Bronte V (2016) Immune suppressive mechanisms in the tumor microenvironment. Curr Opin Immunol 39:1\u20136","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"2426_CR9","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ (2011) T cell exhaustion. Nat Immunol 12(6):492\u2013499","journal-title":"Nat Immunol"},{"issue":"4","key":"2426_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","volume":"36","author":"KE Pauken","year":"2015","unstructured":"Pauken KE, Wherry EJ (2015) Overcoming T cell exhaustion in infection and cancer. Trends Immunol 36(4):265\u2013276","journal-title":"Trends Immunol"},{"issue":"8","key":"2426_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M (2015) Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 15(8):486\u2013499","journal-title":"Nat Rev Immunol"},{"issue":"19","key":"2426_CR12","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodriguez-Abreu D, Robinson AG, Hui R, Csoszi T, Fulop A et al (2016) Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med 375(19):1823\u20131833","journal-title":"N Engl J Med"},{"issue":"9948","key":"2426_CR13","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(14)60958-2","volume":"384","author":"C Robert","year":"2014","unstructured":"Robert C, Ribas A, Wolchok JD, Hodi FS, Hamid O, Kefford R et al (2014) Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial. Lancet 384(9948):1109\u20131117","journal-title":"Lancet"},{"issue":"4","key":"2426_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1470-2045(15)70076-8","volume":"16","author":"JS Weber","year":"2015","unstructured":"Weber JS, D\u2019Angelo SP, Minor D, Hodi FS, Gutzmer R, Neyns B et al (2015) Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial. Lancet Oncol 16(4):375\u2013384","journal-title":"Lancet Oncol"},{"issue":"19","key":"2426_CR15","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","volume":"373","author":"RJ Motzer","year":"2015","unstructured":"Motzer RJ, Escudier B, McDermott DF, George S, Hammers HJ, Srinivas S et al (2015) Nivolumab versus everolimus in advanced renal-cell carcinoma. N Engl J Med 373(19):1803\u20131813","journal-title":"N Engl J Med"},{"issue":"10088","key":"2426_CR16","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","volume":"389","author":"AB El-Khoueiry","year":"2017","unstructured":"El-Khoueiry AB, Sangro B, Yau T et al (2017) Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial[J]. The Lancet 389(10088):2492\u20132502","journal-title":"The Lancet"},{"issue":"1","key":"2426_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/JID.2015.404","volume":"136","author":"T Inozume","year":"2016","unstructured":"Inozume T, Yaguchi T, Furuta J, Harada K, Kawakami Y, Shimada S (2016) Melanoma cells control antimelanoma CTL responses via interaction between TIGIT and CD155 in the effector phase. J Invest Dermatol 136(1):255\u2013263","journal-title":"J Invest Dermatol"},{"issue":"4","key":"2426_CR18","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.immuni.2014.02.012","volume":"40","author":"N Joller","year":"2014","unstructured":"Joller N, Lozano E, Burkett PR, Patel B, Xiao S, Zhu C et al (2014) Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity 40(4):569\u2013581","journal-title":"Immunity"},{"issue":"11","key":"2426_CR19","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1172\/JCI81187","volume":"125","author":"S Kurtulus","year":"2015","unstructured":"Kurtulus S, Sakuishi K, Ngiow SF, Joller N, Tan DJ, Teng MW et al (2015) TIGIT predominantly regulates the immune response via regulatory T cells. J Clin Investig 125(11):4053\u20134062","journal-title":"J Clin Investig"},{"issue":"5","key":"2426_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/ni.2850","volume":"15","author":"CJ Chan","year":"2014","unstructured":"Chan CJ, Martinet L, Gilfillan S, Souza-Fonseca-Guimaraes F, Chow MT, Town L et al (2014) The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions. Nat Immunol 15(5):431\u2013438","journal-title":"Nat Immunol"},{"issue":"5","key":"2426_CR21","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1172\/JCI80445","volume":"125","author":"JM Chauvin","year":"2015","unstructured":"Chauvin JM, Pagliano O, Fourcade J, Sun Z, Wang H, Sander C et al (2015) TIGIT and PD-1 impair tumor antigen-specific CD8(+) T cells in melanoma patients. J Clin Investig 125(5):2046\u20132058","journal-title":"J Clin Investig"},{"issue":"6","key":"2426_CR22","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","volume":"26","author":"RJ Johnston","year":"2014","unstructured":"Johnston RJ, Comps-Agrar L, Hackney J, Yu X, Huseni M, Yang Y et al (2014) The immunoreceptor TIGIT regulates antitumor and antiviral CD8(+) T cell effector function. Cancer Cell 26(6):923\u2013937","journal-title":"Cancer Cell"},{"key":"2426_CR23","doi-asserted-by":"publisher","first-page":"152930","DOI":"10.1016\/j.phymed.2019.152930","volume":"62","author":"X Liu","year":"2019","unstructured":"Liu X, Li M, Wang X et al (2019) Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma. Phytomedicine 62:152930","journal-title":"Phytomedicine"},{"issue":"2","key":"2426_CR24","doi-asserted-by":"publisher","first-page":"e12716","DOI":"10.1111\/acel.12716","volume":"17","author":"Y Song","year":"2018","unstructured":"Song Y, Wang B, Song R et al (2018) T-cell immunoglobulin and ITIM domain contributes to CD 8 + T-cell immunosenescence. Aging Cell 17(2):e12716","journal-title":"Aging Cell"},{"issue":"1","key":"2426_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jhep.2012.08.017","volume":"58","author":"T Motomura","year":"2013","unstructured":"Motomura T, Shirabe K, Mano Y, Muto J, Toshima T, Umemoto Y et al (2013) Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol 58(1):58\u201364","journal-title":"J Hepatol"},{"issue":"2","key":"2426_CR26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/SLA.0b013e318297ad6b","volume":"258","author":"Y Mano","year":"2013","unstructured":"Mano Y, Shirabe K, Yamashita Y, Harimoto N, Tsujita E, Takeishi K et al (2013) Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg 258(2):301\u2013305","journal-title":"Ann Surg"},{"issue":"6","key":"2426_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/jnci\/dju124","volume":"106","author":"AJ Templeton","year":"2014","unstructured":"Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FE, Aneja P, Ocana A et al (2014) Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 106(6):24","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2426_CR28","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00262-008-0516-3","volume":"58","author":"H Cho","year":"2009","unstructured":"Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT et al (2009) Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother CII 58(1):15\u201323","journal-title":"Cancer Immunol Immunother CII"},{"issue":"9","key":"2426_CR29","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1182\/blood-2003-03-0927","volume":"102","author":"V Jankovic","year":"2003","unstructured":"Jankovic V, Messaoudi I, Nikolich-Zugich J (2003) Phenotypic and functional T-cell aging in rhesus macaques (Macaca mulatta): differential behavior of CD4 and CD8 subsets. Blood 102(9):3244\u20133251","journal-title":"Blood"},{"issue":"1","key":"2426_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ni.1679","volume":"10","author":"SD Blackburn","year":"2009","unstructured":"Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A et al (2009) Coregulation of CD8\u2009+\u2009T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10(1):29\u201337","journal-title":"Nat Immunol"},{"issue":"7077","key":"2426_CR31","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH et al (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439(7077):682\u2013687","journal-title":"Nature"},{"issue":"7","key":"2426_CR32","doi-asserted-by":"publisher","first-page":"e1004251","DOI":"10.1371\/journal.ppat.1004251","volume":"10","author":"M Buggert","year":"2014","unstructured":"Buggert M, Tauriainen J, Yamamoto T, Frederiksen J, Ivarsson MA, Michaelsson J et al (2014) T-bet and Eomes are differentially linked to the exhausted phenotype of CD8\u2009+\u2009T cells in HIV infection. PLoS Pathog 10(7):e1004251","journal-title":"PLoS Pathog"},{"issue":"6","key":"2426_CR33","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.immuni.2012.08.021","volume":"37","author":"TA Doering","year":"2012","unstructured":"Doering TA, Crawford A, Angelosanto JM, Paley MA, Ziegler CG, Wherry EJ (2012) Network analysis reveals centrally connected genes and pathways involved in CD8\u2009+\u2009T cell exhaustion versus memory. Immunity 37(6):1130\u20131144","journal-title":"Immunity"},{"issue":"4","key":"2426_CR34","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/ijc.25397","volume":"128","author":"F Shi","year":"2011","unstructured":"Shi F, Shi M, Zeng Z, Qi RZ, Liu ZW, Zhang JY et al (2011) PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients. Int J Cancer 128(4):887\u2013896","journal-title":"Int J Cancer"},{"issue":"9","key":"2426_CR35","doi-asserted-by":"publisher","first-page":"e23621","DOI":"10.1371\/journal.pone.0023621","volume":"6","author":"Z Zeng","year":"2011","unstructured":"Zeng Z, Shi F, Zhou L, Zhang MN, Chen Y, Chang XJ et al (2011) Upregulation of circulating PD-L1\/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma. PLoS One 6(9):e23621","journal-title":"PLoS One"},{"issue":"3","key":"2426_CR36","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1158\/1078-0432.CCR-08-1608","volume":"15","author":"Q Gao","year":"2009","unstructured":"Gao Q, Wang XY, Qiu SJ, Yamato I, Sho M, Nakajima Y et al (2009) Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma. Clin Cancer Res 15(3):971\u2013979","journal-title":"Clin Cancer Res"},{"issue":"12","key":"2426_CR37","doi-asserted-by":"publisher","first-page":"e1254855","DOI":"10.1080\/2162402X.2016.1254855","volume":"5","author":"Q Zhao","year":"2016","unstructured":"Zhao Q, Huang ZL, He M, Gao Z, Kuang DM (2016) BTLA identifies dysfunctional PD-1-expressing CD4(+) T cells in human hepatocellular carcinoma. Oncoimmunology 5(12):e1254855","journal-title":"Oncoimmunology"},{"issue":"8","key":"2426_CR38","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1002\/eji.201243072","volume":"43","author":"N Stanietsky","year":"2013","unstructured":"Stanietsky N, Rovis TL, Glasner A, Seidel E, Tsukerman P, Yamin R et al (2013) Mouse TIGIT inhibits NK-cell cytotoxicity upon interaction with PVR. Eur J Immunol 43(8):2138\u20132150","journal-title":"Eur J Immunol"},{"issue":"3","key":"2426_CR39","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/cdd.2012.141","volume":"20","author":"S Liu","year":"2013","unstructured":"Liu S, Zhang H, Li M, Hu D, Li C, Ge B et al (2013) Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells. Cell Death Differ 20(3):456\u2013464","journal-title":"Cell Death Differ"},{"issue":"25","key":"2426_CR40","doi-asserted-by":"publisher","first-page":"17647","DOI":"10.1074\/jbc.M114.572420","volume":"289","author":"M Li","year":"2014","unstructured":"Li M, Xia P, Du Y, Liu S, Huang G, Chen J et al (2014) T-cell immunoglobulin and ITIM domain (TIGIT) receptor\/poliovirus receptor (PVR) ligand engagement suppresses interferon-gamma production of natural killer cells via beta-arrestin 2-mediated negative signaling. J Biol Chem 289(25):17647\u201317657","journal-title":"J Biol Chem"},{"issue":"1","key":"2426_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ni.1674","volume":"10","author":"X Yu","year":"2009","unstructured":"Yu X, Harden K, Gonzalez LC, Francesco M, Chiang E, Irving B et al (2009) The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol 10(1):48\u201357","journal-title":"Nat Immunol"},{"issue":"2","key":"2426_CR42","doi-asserted-by":"publisher","first-page":"e0170605","DOI":"10.1371\/journal.pone.0170605","volume":"12","author":"X Liu","year":"2017","unstructured":"Liu X, He L, Han J, Wang L, Li M, Jiang Y et al (2017) Association of neutrophil-lymphocyte ratio and T lymphocytes with the pathogenesis and progression of HBV-associated primary liver cancer. PLoS One 12(2):e0170605","journal-title":"PLoS One"},{"issue":"8","key":"2426_CR43","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","volume":"77","author":"EJ Wherry","year":"2003","unstructured":"Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R (2003) Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 77(8):4911\u20134927","journal-title":"J Virol"},{"issue":"7652","key":"2426_CR44","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nature22079","volume":"545","author":"AC Huang","year":"2017","unstructured":"Huang AC, Postow MA, Orlowski RJ, Mick R, Bengsch B, Manne S et al (2017) T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature 545(7652):60\u201365","journal-title":"Nature"},{"issue":"19","key":"2426_CR45","doi-asserted-by":"publisher","first-page":"8934","DOI":"10.1128\/JVI.00798-16","volume":"90","author":"E Ahn","year":"2016","unstructured":"Ahn E, Youngblood B, Lee J, Lee J, Sarkar S, Ahmed R (2016) Demethylation of the PD-1 promoter is imprinted during the effector phase of CD8 T cell exhaustion. J Virol 90(19):8934\u20138946","journal-title":"J Virol"},{"issue":"1","key":"2426_CR46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/JID.2015.404","volume":"136","author":"T Inozume","year":"2016","unstructured":"Inozume T, Yaguchi T, Furuta J, Harada K, Kawakami Y, Shimada S (2016) Melanoma cells control antimelanoma CTL responses via interaction between TIGIT and CD155 in the effector phase. J Invest Dermatol 136(1):255\u2013263","journal-title":"J Invest Dermatol"},{"issue":"29","key":"2426_CR47","doi-asserted-by":"publisher","first-page":"E5900","DOI":"10.1073\/pnas.1706559114","volume":"114","author":"V Chew","year":"2017","unstructured":"Chew V, Lai L, Pan L, Lim CJ, Li J, Ong R et al (2017) Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci USA 114(29):E5900\u2013E5909","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-019-02426-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-019-02426-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-019-02426-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T09:04:28Z","timestamp":1650186268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-019-02426-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2426"],"URL":"https:\/\/doi.org\/10.1007\/s00262-019-02426-5","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"assertion":[{"value":"31 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethics committee of Beijing Ditan Hospital, Capital Medical University (2016-1-28).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent standards"}},{"value":"Each patient and healthy donors signed an informed consent. They all agreed to use their specimens and clinical information for this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}